We are pleased to unveil
a new look for Innovation at OBG!
See it here
Case Study

Repurposing Facilities to Create Productive Assets for Major Pharmaceutical Company

Every Challenge Has a Backstory

The footprints of many pharmaceutical companies have changed over the past two decades. Mergers among top global players and more efficient workspaces have changed the focus of many companies toward consolidation, divestiture, and creating flexible spaces for biopharmaceutical manufacturing processes. These companies have undertaken consolidation programs to reduce their footprint, maximize building efficiency, improve workplace environments, and reduce operating costs.

In line with these industry challenges, a major pharmaceutical and healthcare company sought a strategic partner to help implement environmental remediation, abatement, decontamination, demolition, and redevelopment programs at research and manufacturing facilities across the U.S.

OBG’s Focus on Solutions

As a partner to this pharmaceutical client over the past 10 years, OBG has provided services in support of operational needs and business strategies, as well as solutions to improve restoration at operating and inactive pharmaceutical sites. Services have included strategic master planning, estimating and scheduling, design, implementation, and reuse processes for plant closure and consolidation at multiple facilities.